Speakers
- T. Björk-Eriksson (Sahlgrenska University Hospital, Sweden)
- J. Bussink (Radboud University, The Netherlands)
- J. Capala (National Cancer Institute, USA)
- D. Chen (UT Southwestern Medical Center, USA)
- M. Durante (GSI Helmholtz Centre for Heavy Ion Research, Darmstadt, Germany)
- R. Dziadziuszko (Medical University of Gdańsk, Poland)
- J. Fijuth (Regional Cancer Center, Łódź, Poland)
- A. Gasińska (Institute of Oncology, Kraków, Poland)
- J. Habrand (Centre François Baclesse, France)
- T. Kajdrowicz (IFJ PAN, Poland)
- A. Kawecki (Institute of Oncology, Warsaw, Poland)
- J. Kubeš (Proton Therapy Centre, Prague, Czech Republic)
- P. Kukołowicz (Institute of Oncology, Warsaw, Poland)
- P. Lambin (Universiteit Maastricht, The Netherlands)
- B. Maciejewski (Institute of Oncology, Gliwice, Poland)
- M. Marchetti (Istituto Neurologico Carlo Besta, Italy)
- A. Markiewicz (University Hospital of Kraków, Poland)
- R. Mayer (EBG MedAustron, Austria)
- L. Miszczyk (Institute of Oncology, Gliwice, Poland)
- A. Napieralska (Institute of Oncology, Gliwice, Poland)
- J. Niemiec (Institute of Oncology, Kraków, Poland)
- H. Nystrom (The Skandion Clinic, Sweden)
- P. Olko (IFJ PAN, Poland)
- H. Paganetti (Harvard Medical School, USA)
- A. Pompos (UT Southwestern Medical Center, USA)
- B. Romanowska-Dixon (University Hospital of Kraków, Poland)
- B. Sas-Korczyńska (Institute of Oncology, Kraków, Poland)
- K. Składowski (Institute of Oncology, Gliwice, Poland)
- L. Stolarczyk (IFJ PAN, Poland)
- M. Story (UT Southwestern Medical Center, USA)
- R. Suwiński (Institute of Oncology, Gliwice, Poland)
- J. Swakoń (IFJ PAN, Poland)
- R. Tarnawski (Institute of Oncology, Gliwice, Poland)
- P. van Houtte (University of Brussels, Belgium)
- C. West (Christie Hospital NHS Foundation Trust, UK)
- P. Widłak (Institute of Oncology, Gliwice, Poland)
- G. Wilson (Beaumont Hospital, USA)